Literature DB >> 32616572

Premature termination codons in the DMD gene cause reduced local mRNA synthesis.

Raquel García-Rodríguez1, Monika Hiller1, Laura Jiménez-Gracia1, Zarah van der Pal1, Judit Balog1, Kevin Adamzek1, Annemieke Aartsma-Rus1, Pietro Spitali2.   

Abstract

Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene leading to the presence of premature termination codons (PTC). Previous transcriptional studies have shown reduced DMD transcript levels in DMD patient and animal model muscles when PTC are present. Nonsense-mediated decay (NMD) has been suggested to be responsible for the observed reduction, but there is no experimental evidence supporting this claim. In this study, we aimed to investigate the mechanism responsible for the drop in DMD expression levels in the presence of PTC. We observed that the inhibition of NMD does not normalize DMD gene expression in DMD. Additionally, in situ hybridization showed that DMD messenger RNA primarily localizes in the nuclear compartment, confirming that a cytoplasmic mechanism like NMD indeed cannot be responsible for the observed reduction. Sequencing of nascent RNA to explore DMD transcription dynamics revealed a lower rate of DMD transcription in patient-derived myotubes compared to healthy controls, suggesting a transcriptional mechanism involved in reduced DMD transcript levels. Chromatin immunoprecipitation in muscle showed increased levels of the repressive histone mark H3K9me3 in mdx mice compared to wild-type mice, indicating a chromatin conformation less prone to transcription in mdx mice. In line with this finding, treatment with the histone deacetylase inhibitor givinostat caused a significant increase in DMD transcript expression in mdx mice. Overall, our findings show that transcription dynamics across the DMD locus are affected by the presence of PTC, hinting at a possible epigenetic mechanism responsible for this process.

Entities:  

Keywords:  Duchenne muscular dystrophy; RNA degradation; nascent RNA; premature termination codons; skeletal muscle

Mesh:

Substances:

Year:  2020        PMID: 32616572      PMCID: PMC7368324          DOI: 10.1073/pnas.1910456117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  Stability of the human dystrophin transcript in muscle.

Authors:  C N Tennyson; Q Shi; R G Worton
Journal:  Nucleic Acids Res       Date:  1996-08-01       Impact factor: 16.971

2.  STAR: ultrafast universal RNA-seq aligner.

Authors:  Alexander Dobin; Carrie A Davis; Felix Schlesinger; Jorg Drenkow; Chris Zaleski; Sonali Jha; Philippe Batut; Mark Chaisson; Thomas R Gingeras
Journal:  Bioinformatics       Date:  2012-10-25       Impact factor: 6.937

3.  Regulation of chromatin structure by site-specific histone H3 methyltransferases.

Authors:  S Rea; F Eisenhaber; D O'Carroll; B D Strahl; Z W Sun; M Schmid; S Opravil; K Mechtler; C P Ponting; C D Allis; T Jenuwein
Journal:  Nature       Date:  2000-08-10       Impact factor: 49.962

4.  Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.

Authors:  Sebahattin Cirak; Virginia Arechavala-Gomeza; Michela Guglieri; Lucy Feng; Silvia Torelli; Karen Anthony; Stephen Abbs; Maria Elena Garralda; John Bourke; Dominic J Wells; George Dickson; Matthew J A Wood; Steve D Wilton; Volker Straub; Ryszard Kole; Stephen B Shrewsbury; Caroline Sewry; Jennifer E Morgan; Kate Bushby; Francesco Muntoni
Journal:  Lancet       Date:  2011-07-23       Impact factor: 79.321

5.  Preclinical PK and PD studies on 2'-O-methyl-phosphorothioate RNA antisense oligonucleotides in the mdx mouse model.

Authors:  Hans Heemskerk; Christa de Winter; Petra van Kuik; Niki Heuvelmans; Patrizia Sabatelli; Paola Rimessi; Paola Braghetta; Gert-Jan B van Ommen; Sjef de Kimpe; Alessandra Ferlini; Annemieke Aartsma-Rus; Judith C T van Deutekom
Journal:  Mol Ther       Date:  2010-04-20       Impact factor: 11.454

6.  Antisense oligonucleotide-induced exon skipping across the human dystrophin gene transcript.

Authors:  Steve D Wilton; Abbie M Fall; Penny L Harding; Graham McClorey; Catherine Coleman; Susan Fletcher
Journal:  Mol Ther       Date:  2007-02-06       Impact factor: 11.454

7.  Coordinated histone H3 methylation and acetylation regulate physiologic and pathologic fas ligand gene expression in human CD4+ T cells.

Authors:  Smita S Ghare; Swati Joshi-Barve; Akshata Moghe; Madhuvanti Patil; David F Barker; Leila Gobejishvili; Guy N Brock; Matthew Cave; Craig J McClain; Shirish S Barve
Journal:  J Immunol       Date:  2014-06-04       Impact factor: 5.422

8.  DMD transcript imbalance determines dystrophin levels.

Authors:  Pietro Spitali; Janneke C van den Bergen; Ingrid E C Verhaart; Beatrijs Wokke; Anneke A M Janson; Rani van den Eijnde; Johan T den Dunnen; Jeroen F J Laros; Jan J G M Verschuuren; Peter A C 't Hoen; Annemieke Aartsma-Rus
Journal:  FASEB J       Date:  2013-08-23       Impact factor: 5.191

9.  Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors.

Authors:  G C Minetti; C Colussi; R Adami; C Serra; C Mozzetta; V Parente; S Fortuni; S Straino; M Sampaolesi; M Di Padova; B Illi; P Gallinari; C Steinkühler; M C Capogrossi; V Sartorelli; R Bottinelli; C Gaetano; P L Puri
Journal:  Nat Med       Date:  2006-09-17       Impact factor: 53.440

10.  An Assessment of Fixed and Native Chromatin Preparation Methods to Study Histone Post-Translational Modifications at a Whole Genome Scale in Skeletal Muscle Tissue.

Authors:  Sarah-Anne David; Benoît Piégu; Christelle Hennequet-Antier; Maëlle Pannetier; Tiphaine Aguirre-Lavin; Sabine Crochet; Thierry Bordeau; Nathalie Couroussé; Aurélien Brionne; Yves Bigot; Anne Collin; Vincent Coustham
Journal:  Biol Proced Online       Date:  2017-08-29       Impact factor: 3.244

View more
  5 in total

1.  Genetic correction strategies for Duchenne Muscular Dystrophy and their impact on the heart.

Authors:  Jamie R Johnston; Elizabeth M McNally
Journal:  Prog Pediatr Cardiol       Date:  2021-11-02

2.  Optogenetic modeling of human neuromuscular circuits in Duchenne muscular dystrophy with CRISPR and pharmacological corrections.

Authors:  Amaia Paredes-Redondo; Peter Harley; Eleni Maniati; David Ryan; Sandra Louzada; Jinhong Meng; Anna Kowala; Beiyuan Fu; Fengtang Yang; Pentao Liu; Silvia Marino; Olivier Pourquié; Francesco Muntoni; Jun Wang; Ivo Lieberam; Yung-Yao Lin
Journal:  Sci Adv       Date:  2021-09-10       Impact factor: 14.957

3.  Muscle regeneration affects Adeno Associated Virus 1 mediated transgene transcription.

Authors:  Sofia Benkhelifa-Ziyyat; Stéphanie Lorain; Amédée Mollard; Cécile Peccate; Anne Forand; Julie Chassagne; Laura Julien; Pierre Meunier; Zoheir Guesmia; Thibaut Marais; Marc Bitoun; France Piétri-Rouxel
Journal:  Sci Rep       Date:  2022-06-11       Impact factor: 4.996

4.  Alternative Polyadenylation Utilization Results in Ribosome Assembly and mRNA Translation Deficiencies in a Model for Muscle Aging.

Authors:  Hailiang Mei; Jasper Boom; Salma El Abdellaoui; Kotb Abdelmohsen; Rachel Munk; Jennifer L Martindale; Susan Kloet; Szymone M Kielbasa; Thomas H Sharp; Myriam Gorospe; Vered Raz
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-06-01       Impact factor: 6.591

Review 5.  Exon-Skipping in Duchenne Muscular Dystrophy.

Authors:  Shin'ichi Takeda; Paula R Clemens; Eric P Hoffman
Journal:  J Neuromuscul Dis       Date:  2021
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.